MainboardGMP
LIVE
LIVE GMP
MakeMyTrip (India) Ltd₹0·Sagar Defence Engineering Ltd₹0·Encube Ethicals Ltd₹0·Arjun Jewellers Ltd₹0·Atomberg Technologies Ltd₹0·GNI Infrastructure Ltd₹0·Punjab Carbonic Ltd₹0·Ratnadeep Retail Ltd.₹0·IFL Finance Ltd.₹0·J Pan Tubular Components Ltd₹0·MakeMyTrip (India) Ltd₹0·Sagar Defence Engineering Ltd₹0·Encube Ethicals Ltd₹0·Arjun Jewellers Ltd₹0·Atomberg Technologies Ltd₹0·GNI Infrastructure Ltd₹0·Punjab Carbonic Ltd₹0·Ratnadeep Retail Ltd.₹0·IFL Finance Ltd.₹0·J Pan Tubular Components Ltd₹0·
Home › IPOs › Meesho Ltd. › Subscription
ME
Meesho Ltd.
CLOSED NSE & BSE Bookbuilding IPO Fresh Capital-cum-Offer for Sale Meesho IPO GMP
GREY MARKET PREMIUM
₹ 0
No premium data
EST. LISTING PRICE
₹111
Issue Price: ₹ 111
Back to IPOs Check Allotment Website
Issue Price
₹111
Face Value
₹1
Lot Size
135 shares
Open Date
03 Dec 2025
Close Date
05 Dec 2025
Allotment
08 Dec 2025
Listing Date
10 Dec 2025
Exchange
NSE & BSE

Meesho IPO Details: Price, Dates & Financials

The Meesho IPO GMP strength score is 5.7 out of 10, which the dashboard rates as Moderate. The Meesho IPO QIB category is reserved for 75% of the offer. The Meesho IPO NII/HNI category is reserved for 15% of the offer. The Meesho IPO Retail (RII) category is reserved for 10% of the offer. Live subscription numbers for the Meesho IPO are not yet available, and amounts are calculated at the upper price band of ₹111.

IPO Analytics Dashboard
LIVE
Meesho IPO GMP Insights
👤
Retail Demand
Weak
💼
HNI Interest
Good
🏦
QIB Demand
Strong
📊
Valuation
Moderate
Meesho IPO GMP Strength Score
6 / 10 Moderate
0–3 Weak 3–6 Moderate 6–8 Good 8–10 Strong
Meesho IPO Category-wise Subscription Shares offered, bid & amount
Category Sub (x) Offered Bid For
🏦 QIB — 366,297,541 (75%) —
💼 NII / HNI — 73,259,508 (15%) —
👤 Retail (RII) — 48,839,672 (10%) —
Σ Total — 488,396,721 (100%) —

* Amount calculated at upper price band (₹111) ·  ** Total includes all investor categories

Subscription Overview Share allocation by investor category
🏦
QIB ? 366,297,541 (75%)
75%
💼
NII / HNI ? 73,259,508 (15%)
15%
👤
Retail (RII) ? 48,839,672 (10%)
10%
Total Shares Offered 488,396,721 (100%)
Meesho IPO Application Sizing Minimum investment by category
👤 Retail Investors ?
Min. Lots 1
Shares / Lot 135
Min. Investment ₹14,985
💼 HNI Investors ?
Min. Lots 67
Min. Shares 9,045
Min. Investment ₹1,003,995
Meesho IPO Valuation — EPS & P/E Pre & post-issue metrics
Pre-Issue EPS ?
₹ -10
Post-Issue EPS ?
₹ -3
Pre-Issue P/E ?
-12 x
Post-Issue P/E ?
-36 x
Meesho IPO Timeline & Key Dates
  1. 1 💳 Initiation of Refund 09 Dec 2025
  2. 2 📂 Credit of Shares to Demat 09 Dec 2025
Investor Interpretation
  • Retail allocation is weak at 10% of the total offering.
  • HNI/NII demand is good at 15%.
  • Institutional (QIB) interest is strong at 75%.
  • Pre-issue EPS of ₹-10 compares to post-issue EPS of ₹-3 after dilution.

This IPO has relatively lower interest or stretched valuation. Proceed with thorough research and caution.

✅ Check Allotment Status
Meesho IPO Subscription FAQs
Subscription data for Meesho IPO is not available right now. Numbers are updated here during the bidding window.
In Meesho IPO, retail investors can apply for a minimum of 1 lot(s) (₹₹14,985); HNI/sNII minimum 67 lots (₹₹1,003,995).
Shares offered by category — QIB 366,297,541 (75%) shares, Retail 48,839,672 (10%) shares.
Meesho IPO valuation — pre-issue EPS ₹-9.54, post-issue EPS ₹-3.11, pre-issue P/E -11.63, post-issue P/E -35.75.
Subscription is shares bid for divided by shares offered in that category. If 10 lakh shares are offered and 50 lakh are bid for, the category is subscribed 5 times. Final numbers are confirmed after the bidding closes.
The NII category covers investors applying for shares outside the retail investor category, while HNI commonly refers to high-value investors within the NII category. Understanding the Meesho IPO's NII and HNI subscription levels helps investors assess demand for the Meesho IPO and overall investor interest.

GMP and IPO data are unofficial and for information only — not investment advice. Read the full disclaimer.